Chronic kidney disease guideline

Issue: BCMJ, vol. 57, No. 2, March 2015, Page 72 News

The Chronic Kidney Disease: Identification, Evaluation, and Management of Adult Patients guideline provides recommendations for investigating, evaluating, and managing adults aged 19 years or older who are at risk of or with known chronic kidney disease, including care objectives and patient self-management. Specialized management of established chronic kidney disease (e.g., erythropoietic agents for anemia; renal replacement therapy; and treatment of calcium, phosphate, or parathyroid hormone abnormalities) is beyond the scope of this guideline. 

Key recommendations
•    Identify high-risk patient groups for evaluation of chronic kidney disease.
•    Measure both estimated glomerular filtration rate and urine albumin/creatinine ratio for evaluation and prognosis purposes.
•    Determine cause of kidney disease where possible. The three dimensions of cause, estimated glomerular filtration rate, and albuminuria are all important in developing a management plan (new in the 2014 guideline).
•    The word “microalbumin” has been previously used to describe small amounts of protein in urine; however, recent guidelines and consensus recommend abandoning the term and using the albumin/creatinine ratio value instead.
•    In consultation with the patient and family/caregivers, develop an individualized management plan.
•    Ensure timely referral to specialists and health care teams as appropriate.

For the complete listing of BC guidelines, visit www.bcguidelines.ca.

Physicians interested in participating in the development of future guidelines and protocols are encouraged to e-mail hlth.guidelines@gov.bc.ca. Physician participation in guidelines and protocols development is compensated at the Doctors of BC sessional rate.

. Chronic kidney disease guideline. BCMJ, Vol. 57, No. 2, March, 2015, Page(s) 72 - News.


Above is the information needed to cite this article in your paper or presentation. The International Committee of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

About the ICMJE and citation styles

The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.

An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.

BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:

  • Only the first three authors are listed, followed by "et al."
  • There is no period after the journal name.
  • Page numbers are not abbreviated.


For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org

BCMJ Guidelines for Authors

Leave a Reply